RECOMBUMIN Trademark

Trademark Overview


On Thursday, May 6, 2021, a trademark application was filed for RECOMBUMIN with the United States Patent and Trademark Office. The USPTO has given the RECOMBUMIN trademark a serial number of 79322951. The federal status of this trademark filing is REGISTERED as of Tuesday, December 20, 2022. This trademark is owned by Albumedix Ltd. The RECOMBUMIN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical products and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, haematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for medical or veterinary purposes, namely, the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, haematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders

Chemicals used in industry, science and for use in the manufacture of pharmaceuticals, chemical reagents other than for medical or veterinary purposes; diagnostic reagents, other than for medical or veterinary purposes; proteins for industrial purposes; albumin for use in industrial purposes and in the manufacture of pharmaceuticals; albumin for use in the manufacture of pharmaceutical products
recombumin

General Information


Serial Number79322951
Word MarkRECOMBUMIN
Filing DateThursday, May 6, 2021
Status700 - REGISTERED
Status DateTuesday, December 20, 2022
Registration Number6926876
Registration DateTuesday, December 20, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements


Description of MarkThe mark consists of the word "RECOMBUMIN" in a black stylized font with a red organic heart shape substituting the letter "O" in the word "RECOMBUMIN".
Goods and ServicesPharmaceutical products and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, haematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for medical or veterinary purposes, namely, the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, haematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders
Indication of Colors claimedThe color(s) red and black is/are claimed as a feature of the mark.
Goods and ServicesChemicals used in industry, science and for use in the manufacture of pharmaceuticals, chemical reagents other than for medical or veterinary purposes; diagnostic reagents, other than for medical or veterinary purposes; proteins for industrial purposes; albumin for use in industrial purposes and in the manufacture of pharmaceuticals; albumin for use in the manufacture of pharmaceutical products

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlbumedix Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAlbumedix Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAlbumedix Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, April 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, April 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 4, 2023FINAL DISPOSITION PROCESSED
Sunday, April 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 20, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, January 29, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 20, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Monday, October 3, 2022NOTIFICATION PROCESSED BY IB
Wednesday, September 14, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 14, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 1, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 28, 2022REFUSAL PROCESSED BY IB
Wednesday, February 9, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 9, 2022REFUSAL PROCESSED BY MPU
Wednesday, January 19, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 18, 2022NON-FINAL ACTION WRITTEN
Tuesday, January 11, 2022ASSIGNED TO EXAMINER
Tuesday, October 19, 2021APPLICATION FILING RECEIPT MAILED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 14, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB